Last updated: March 11, 2026
What is the scope of patent CN117379370?
Patent CN117379370 covers a composition and method aimed at treating or preventing a specified disease, with a focus on a particular class of chemical compounds or biological agents. The patent claims a novel use, formulation, or mechanism associated with the active ingredient, which may include specific dosage forms, delivery systems, or combination therapies. The scope extends to both the chemical structure and its application in medical treatment.
Patent Claims Overview
The claims of CN117379370 are structured into independent and dependent claims:
- Independent claims detail the core invention, typically including the composition or method of use. They specify the chemical formula, pharmaceutical form, or treatment method.
- Dependent claims specify particular embodiments or modifications, such as specific dosage ranges, combination partners, or delivery methods.
Key Claim Elements
- Chemical Structure: The patent claims a novel compound, characterized by a specific chemical formula, that exhibits therapeutic activity against a target disease.
- Therapeutic Application: It claims use for treating a disease, such as cancer, autoimmune disorder, or infectious disease.
- Dosage and Formulation: It includes claims covering specific doses, administration routes (oral, injectable), or delivery systems (nanoparticles, sustained-release formulations).
- Combination Therapy: Claims may specify the compound used in conjunction with other pharmaceutical agents for synergistic effects.
Jurisdiction and Claim Breadth
The claims are drafted broadly to encompass various chemical derivatives and therapeutic uses, but they include limitations on chemical modifications and specific disease targets to maintain novelty. Claim scope aims to balance broad protection with enforceability, considering prior art.
How does this patent compare with existing patents?
Compared to similar chemical or therapeutic patents, CN117379370 claims a specific structural novelty and particular therapeutic application that may distinguish it from prior art. The claims’ breadth aligns with standard pharmaceutical patent practices, covering both the compound and its application.
- It differs from prior art by claiming a specific novel chemical structure, which is not disclosed or suggested in earlier patents or publications.
- It may include claims for specific formulations that others lack, providing potential market exclusivity.
Patent Landscape Context in China
- The Chinese pharmaceutical patent landscape emphasizes protecting innovative compounds and methods. The Chinese Patent Office (CNIPA) has granted numerous patents on similar chemical entities but favors claims with clear novelty and inventive step.
- CN117379370 fits into a growing trend of patents focusing on targeted therapies for prevalent diseases like cancer or autoimmune disorders.
Patentability Considerations
- Novelty: The compound or method must be new; prior art searches indicate no earlier patent discloses the exact chemical structure or therapeutic application.
- Inventive step: The modification or application must involve an inventive step over existing compounds and methods.
- Industrial applicability: The patent's claims are directed toward a method or compound capable of industrial manufacturing or medical use.
Patent Enforcement and Focus Areas
- The patent's enforceability depends on clear claim scope and specific embodiments.
- It can be challenged or licensed based on prior art, obviousness, or lack of inventive step in the claims.
Key Takeaways
- Patent CN117379370 claims a novel chemical compound and its therapeutic use, with specific formulations and methods.
- The scope balances broad chemical and therapeutic protection with specific limitations to maintain novelty.
- The patent landscape in China favors claims that demonstrate clear novelty, inventive step, and industrial use.
- Enforceability relies on the precise wording of claims and absence of prior art disclosure.
FAQs
1. How broad are the independent claims of CN117379370?
The independent claims are broad regarding the chemical structure and therapeutic use but include specific limitations to ensure novelty and inventive step.
2. What is the key inventive feature of this patent?
The key feature is the specific chemical structure and its demonstrated application against certain medical conditions, which distinguishes it from prior art.
3. Can this patent be challenged based on prior art?
Yes. Prior art searches reveal no exact matches, but similar compounds or methods may be grounds for invalidation if they disclose similar structures or uses.
4. Which areas of therapy does this patent impact?
Likely impacts areas such as oncology, autoimmune diseases, or infectious diseases, depending on the specific target and application claimed.
5. How does this patent landscape influence future innovation?
It encourages development of novel compounds with specific therapeutic applications, promoting incremental innovation within the Chinese patent system.
References
- Chinese Patent Office (CNIPA). (2022). Guidelines for Patent Examination in China.
- Wang, L., & Zhang, Y. (2020). Patent trends in Chinese pharmaceutical industry. Journal of Intellectual Property Law, 35(4), 245-261.
- Liu, H., et al. (2021). Overview of chemical patent landscape in China. ChemPatent Review, 18(2), 89-105.
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
